Twenty-four sexually mature dairy heifers in six groups of four each received 25 mg of prostaglandin F2 ot (PGF200 between days 7 and 14 of the estrous cycle. The control heifers received only this hormone; the other groups of heifers received 500, 1,200 or 2,000 IU of pregnant mare serum gonadotropin (PMSG). Half of the animals in the two latter groups received the PMSG simultaneously with the PGF2ot and half were given the hormone 12 hr later to determine if the ovarian response would be affected by reduced progesterone following PGF2a-induced luteal regression. Ovulation rate was not affected by changes in progesterone prior to PMSG. Each of the eight animals receiving only PGF2a or PGF2a plus 500 IU of PMSG had one ovulation. The average ovulation rate for eight animals receiving 1,200 IU of PMSG was 3.2 (range 1 to 6) and for eight receiving 2,000 IU of PMSG it was 5.6 (range 1 to 19). Duration of increased plasma progesterone concentrations, particularly following the highest dose of PMSG, seems to be more important in determining ovarian response than changes in progesterone prior to PMSG treatment. However, plasma concentrations of estradiol, progesterone and LH did not differ significantly among groups of heifers. Systemic concentrations of plasma progesterone were corre-IT he authors thank International Cryo-Biological Services, Inc. for financial support, Dr. J. W. Lauderdale of The Upjohn Co. for the prosta#andin F 2 a, Dr. A. Campbell and Dr. K. Kirton of the Upjohn Co. for the conjugate used to produce the antibody to progesterone, the Endocrine Study Section, NIH for the PMSG and Eastern A.I. lated with the number of corpora lutea 13 days after treatment (r=.99, P<.001).
INTRODUCTION
Synchronization of estrus with controlled superovulation to induce twinning could be a valuable asset to the cattle industry, but variability in ovulatory response to treatment and low conception rates following treatment have been major problems Bellows and Short, 1972; Johnson et al., 1975) . Several researchers have given follicle stimulating hormone (FSH) or pregnant mare serum gonadotropin (PMSG) as a series of injections, but the results of Bellows and Short (1972) suggest that the size of the last dose given prior to the induced or synchronized estrus is of major importance in determining ovulation rate. Other researchers (Phillippo and Rowson, 1975; Moore, 1975; Tervit et al., 1973; Elsden et al., 1974; Hill et al., 1973) have obtained promising results utilizing prostaglandin F2a (PGF2a) and PMSG. Phillippo and Rowson (1975) observed the highest ovulatory response among animals treated during days 8 to 12 of the estrous cycle and also noted a tendency for two or three follicles to develop when animals were treated during the follicular phase of the cycle with PGF2~ + PMSG rather than PMSG alone. These results suggested to us that the superovulatory response may be affected by the progesterone to estrogen ratio at the time of treatment.
The purpose of this study was to determine if differences in plasma progesterone concentrations at the time of PMSG administration affected the variability of ovulatory response to PMSG. In addition, comparisons were made of the ovulatory and endocrine response of mid-1293 JOURNAL OF ANIMAL SCIENCE, Vol. 46, No. 5, 1978 cycle heifers to PMSG before and after plasma progesterone concentrations were reduced by an injection of PGF2~.
MATERIALS AND METHODS
Animals. Twenty-four Holstein heifers 14 to 24 months of age were utilized. Heifers weighed 280 to 390 kg at the time of treatment. They were maintained on corn and grass silage.
Treatment. On days 7 to 14 of the estrous cycle heifers were assigned randomly to one of six treatment groups to examine the effects of time of PMSG treatment (concurrent with PGF20t vs 12 hr after PGF2ot) and the dose of PMSG administered (0, 500, 1,200, 2,000 IU) on hormone patterns and ovulation rates (table  1 ). An intramuscular injection of 33.5 mg PGF2a Tham salt (25 mg of PGF20t) was used to regress the corpus luteum and synchronize estrus. The PMSG (NIAMDD-PMSG-2, Parlow) was dissolved in sterile saline at a concentration of 200 IU/ml and injected subcutaneously.
Jugular vein samples by venipuncture were collected into citrated tubes before PGF20t treatment, at 4-hr intervals for 84 hr after treatment, and then daily for 10 additional days. Blood was centrifuged and plasma stored at -20 C until assayed. Progesterone concentrations were determined in all samples and luteinizing hormone (LH) and estradiol-173 were assayed in samples collected for 84 hr after PGF 2 a treatment.
Heifers were observed every 4 hr for estrus. Nine to 12 days after PGF2~ treatment, animals were given a local anesthetic and ovaries were examined via a high lumbar laparotomy. bFree acid equivalent.
Radioimmunoassays. Plasma progesterone was analyzed by the method of Apgar et al. (1975) using a specific progesterone antibody produced in ewes against a progesterone-lla hemi-succinate-BSA conjugate. The antibody was tested with 18 steroids (J. E. Hixon, personal communication, Cornell University, 1976 ) and found to have negligible crossreactivity, excepting with corticosterone (17%), 5~-pregnen-3,20-dione (10%) and 203-hydroxypregn-4-en-3-one (7%). The corticosterone in plasma was eliminated by the extraction procedure (Apgar et al., 1975) . Milk pools examined for progesterone content by gas chromatography gave essentially identical values to tile radioimmunoassay procedure using this antibody.
Plasma LH was quantified using the double antibody procedure (Niswender et aL, 1969) with NIH-LH-B9 as the reference standard. The first antibody was GN #15 (G. D. Niswender) and the second antibody was produced in sheep against purified rabbit lgG. Heparin was added to the buffer to prevent clotting of the plasma during the assay.
Plasma estradiol-17/3 was determined, using a highly specific sheep antiserum (G. D. Niswender #244) against 6-keto estradiol oxime conjugate bovine serum albumin. The specificity of this antibody has been described by Korenman et al. (1974) .
The 17/3-estradiol-6-(carboxymethyl) oxime-12 s I-iodohistamine was produced according to the method of Hunter et al. (1975) and was used as the labeled ligand. Plasma samples (200 /A) were extracted in duplicate with 10 volumes of redistilled benzene:toluene (2:1 v/v). The assay procedure used was that of Holt et al. (1975) . Solvent blanks were <.Spg/assay tube. The within-assay coefficient of variation averaged 11.3% over 10 assays. The between assay coefficient of variation based on a sample containing 16.6 pg/ml was 26%. Recovery of cold estradiol added to a plasma sample and parallel dilutions of a sample collected from a cow in estrus are presented in table 2.
Hormone data were treated as a split-plot design. Animals were random and treatments fixed. All data were subjected to analysis of variance (Henderson, 1969) .
R ESU LTS
The estrus and ovulation responses are summarized in table 3. The time of administration Figure 1 . Reladonship between the number of corpora lutea and plasma progesterone concentration 13 days after PMSG treatment.
in animals receiving the higher doses of PMSG. However, grouping animals according to ovulation rates (table 4) revealed significant differences in the intervals to estrus following either PGF20~ or PMSG (P<.05). Heifers with the highest ovulation rates tended to have the longest intervals to estrus. The results are particularly influenced by heifers in which the CL was not regressed by PGF2cx within the 84-hr period. One heifer in each of the two groups treated with PGF20~ and 2,000 IU PMSG did not show estrus until 120 and 144 hr after treatment. These heifers had 16 and 19 ovulations.
Four of the treated heifers exhibited a split estrus about 72 hr apart. The condition did not appear to be influenced by the dose of PMSG because one animal treated with 500 IU, one treated with 1,200 IU and two treated with 2,000 IU of PMSG exhibited the split estrus. Only one heifer appeared to ovulate a follicle at the second estrus as judged by the size and appearance of the CL at the time of laparotomy.
Plasma hormone changes with time for the six groups are shown in figures 2, 3 and 4. Overall, plasma progesterone concentrations declined from about 6 ng/ml at the time of PGF2~, treatment to about 2 ng/ml 12 hr later. Complete luteal regression, as determined by plasma progesterone concentrations below 1 ng/ml by 84 hr, was observed in 20 of 24 heifers. Analysis of variance revealed no significant treatment effect (P>.05) on progesterone concentration during the 84-hr period following treatment. However, a significant (P<.001) time effect was observed.
Plasma LH concentrations were not significantly affected by treatment. However, a significant time effect was observed (P<.05). Following the administration of PGF2a, plasma LH concentrations increased from pretreatment levels of .6 ng/ml to levels in excess of 2 ng/ml by 4 hr post-treatment. In individual animals showing estrus within the 84-hr post-treatment during which LH was measured, the start of the LH peak was accompanied by the onset of estrus. Generally LH tended to reach its peak about 56 hr after treatment. Peak LH concentrations exceeding 40 ng/ml were associated with every heifer observed in estrus. Not all animals in the highest PMSG treatment group (figure 4) underwent complete luteal regression. Consequendy estrus was delayed until after the time LH was measured.
Plasma estradiol in individual heifers increased from pretreatment concentrations of 10 to 30 pg/ml to maxima of 30 to 80 pg/ml with averages given in figures 2 to 4. These maxima generally were observed at the onset of or during estrus, but occasionally this occurred as progesterone declined considerably before estrus. There was no difference (P>.05) in plasma ,;Iit estradiol concentrations among treatment groups or" among animals grouped according to ovulation number. Hence no correlation between plasma estradiol concentration and number of follicles ovulated was calculated. It is interesting to note that during the 84-hr period after treatment the estradiol concentrations in heifers responding to the PGF2~ never exceeded 80 pg/ml, whereas maximum plasma estradiol values of 140 and 180 pg/ml occurred in two of the four heifers not responding to PGF2~ treatment, but having high ovulation rates.
Discussion
Absolute decreases in plasma progesterone concentrations usually occurred rapidly following PGF2~ administration, although not all animals responded to PGF2c,. There was no difference in ovulation rate between groups receiving PGF2(x and PMSG simultaneously, or 12 hr apart, either considering all animals (table 3) or only those with rapid CL regression. With this lack of differential effect of delaying PMSG treatment, all animals treated with the same amount of PMSG are considered as a group in the following discussion.
As expected, the dose of PMSG influenced ovarian response. If ovarian response is defined as the number of corpora lutea plus the number of follicles greater than 1.5 cm at the time of laparotomy, there were four, five and five heifers in the 500, 1,200 and 2,000 IU PMSG-treated groups which responded to PGF2~ and were observed in estrus within the experimental period. The ovarian response in these groups was 2 (1 CL + 1 follicle), 5.7 (4.0 CL + 1.7 follicles) and 6.2 (1.6 CL + 4.6 follicles), respectively. Although the 1,200 and 2,000 IU doses resulted in similar total ovarian responses in heifers which responded to the PGF2~, the 1,200 IU dose resulted in more CL and fewer large follicles than the 2,000 I U dose (X 2 = 25.2, P<.01).
No relationship was observed between estradiol concentration prior to estrus and the number of CL formed. Apparently a sufficient estradiol concentration was achieved in each individual animal to elicit an LH peak and the onset of estrus. While estradiol could be produced by a single mature follicle or a number of less mature follicles, ovulation rate would be a function of the number of follicles which are capable of ovulation at the time of the LH peak. The early LH peak (figure 4, top) may reflect the high dose of PMSG stimulating a more rapid development of a few follicles resulting in an estradiol increase and an earlier LH peak. The mature follicles presumably ovulate and immature follicles grow, resulting in the large follicles observed at laparotomy.
During the experimental period peak estradiol concentration never exceeded 80 pg/ml in any of the five heifers which had low progesterone concentrations, while estradiol concentrations in two of the three heifers with high progesterone exceeded 120 pg/ml. In the presence of endogenous progesterone, estradiol cannot elicit an LH peak (unpublished observations) and more follicles reach maturity and ovulate with the later LH peak after progesterone declines.
Five of the eight heifers treated with 2,000 IU of PMSG had low progesterone concentrations before the end of the 84 hr post-treatment period, averaged 1.6 corpora lutea and 4.6 large follicles and returned to estrus 51.4 hr after treatment. The heifers with higher progesterone concentrations during this period averaged 12.3 corpora lutea and three large follicles and returned to estrus after 120 hours.
These findings are consistent with others which indicated that heifers returning to estrus 2 to 4 days following PMSG or PGF2cz treatment tended to have lower and more uniform ovulation rates than heifers which returned to estrus after 4 days (Turman et al., 1971 ; Hansel and Schechter, 1972; Louis et al., 1972; Rowson et al., 1972; Johnson et al., 1975) .
A positive relationship between the number of CL and plasma progesterone in superovulated cattle has been reported previously (Henricks et al., 1973; Spilman et al., 1973) . However, the plasma concentration of progesterone was much more highly correlated with the number of CL in the present study than previously observed.
The results of the study indicate that the dose of PMSG administered with the PGF2c~ had a pronounced effect on ovarian response. The low dose of PMSG (500 IU) resulted in only one ovulation per animal and a tightly synchronized estrus (55 to 64 hr post-PGF2a). Six of eight heifers treated with 1,200 IU PMSG superovulated with little variability between animals (range 1 to 6). The 2,000 IU dose resulted in the highest average ovulatory response and also the most variable response.
Although it would appear that we can exert some control over the number of follicles which develop, the knowledge of what controls follicle growth in the normal animal may be the key to controlling superovulation. 
